Invention Grant
- Patent Title: System and method for genetic based efficacy testing
-
Application No.: US16674189Application Date: 2019-11-05
-
Publication No.: US11380424B2Publication Date: 2022-07-05
- Inventor: Rob Todd , Jerry Wrobel , John Pigott
- Applicant: Xact Laboratories, LLC
- Applicant Address: US OH Twinsburg
- Assignee: Xact Laboratories, LLC
- Current Assignee: Xact Laboratories, LLC
- Current Assignee Address: US OH Twinsburg
- Agency: Standley Law Group LLP
- Agent Adam J. Smith; Jeffrey S. Standley
- Main IPC: G16H10/40
- IPC: G16H10/40 ; G16H15/00 ; G16H10/60 ; G16H20/10 ; G16H70/40 ; G16H80/00 ; G16H50/70

Abstract:
System and methods for alerting a healthcare provider to prescribed treatments having reduced or no effectiveness due to genetic composition is provided. A database containing treatments known to have reduced or no efficacy in persons having particular genetic markers is queried to determine whether any treatments prescribed by, or likely to be prescribed by, a healthcare provider to the patient are known to have reduced or no efficacy in persons having the same genetic markers as the patient. An alert containing such information is displayed at a healthcare provider system.
Public/Granted literature
- US20200075138A1 SYSTEM AND METHOD FOR GENETIC BASED EFFICACY TESTING Public/Granted day:2020-03-05
Information query